Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY
|
BSE: 500124
|
ISIN: INE089A01031
|
Industry: Pharmaceuticals
Insider Trades
|
Mid-range Performer
1313.3000
-5.50
(
-0.42
%)
NSE
Jun 18, 2025
15:31 PM
28.75% Gain from 52W Low
Volume:
728.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Dr. Reddy's Laboratories Ltd.
26 Jan 2023
Insider Trades
1313.30
-0.42%
Dr Reddy's Labs (HOLD): Strong US sales; recovery in EM and PSAI businesses
Hold:
Dr. Reddy's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 4700
Target
BOB Capital Markets Ltd.
Q3 revenue growth strong at 27% YoY to Rs 67.7bn, supported by US contribution and launches
Number of FII/FPI investors decreased from 927 to 911 in Mar 2025 qtr
More from Dr. Reddy's Laboratories Ltd.
Recommended
Chart of the Week: Profit booking grips promoters as stake sales surge across sectors
The Baseline |
18 Jun 2025, 05:06PM
Market closes lower, HDFC Bank CEO challenges FIR over disputed loan disclosure
Trendlyne Marketwatch |
18 Jun 2025, 03:58PM
Dr Reddy’s Labs struggles in its biggest market
|
18 Aug 2021, 11:13AM